Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Paterson, D L; Ko, W C; Von Gottberg, A; Casellas, J M; Mulazimoglu, L; Klugman, K P; Bonomo, R A; Rice, L B; McCormack, J G; Yu, V L

Paterson, D L; Ko, W C; Von Gottberg, A; Casellas, J M; Mulazimoglu, L; Klugman, K P; Bonomo, R A; Rice, L B; McCormack, J G; Yu, V L.

Affiliation

Paterson DL; Infectious Disease Division, University of Pittsburgh VA Medical Center, University Dr. C, Pittsburgh, PA 15240, USA.

J Clin Microbiol ; 39(6): 2206-12, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11376058

Subject(s)

Bacteremia/drug therapy; Cephalosporins/therapeutic use; Klebsiella Infections/drug therapy; Klebsiella pneumoniae/drug effects; beta-Lactamases/metabolism; Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia/microbiology; Cephalosporins/pharmacology; Child; Female; Genotype; Humans; Infant; Klebsiella Infections/microbiology; Klebsiella pneumoniae/enzymology; Male; Microbial Sensitivity Tests/standards; Middle Aged; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Beta-Lactamases / Klebsiella Infections / Cephalosporins / Bacteremia / Klebsiella pneumoniae Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Infant / Male / Middle aged Language: En Journal: J Clin Microbiol Year: 2001 Document type: Article

Fulltext

XML

PubMed Links

Search on Google